News intelligence for diagnostics, pathology, and governed clinical AI.
Curated market intelligence across New Zealand, Australia, and global healthcare — tracking digital pathology, diagnostics, clinical AI governance, and the areas that matter to Translyx, its partners, and its pipeline.
Precision Medicine Summit 2026: Building the Precision Pathway
The Precision Medicine Summit 2026 in Sydney will bring together clinical and pathology leaders, scientists, and policymakers to discuss delivering precision cancer care. Key topics include implementing Comprehensive Genomic Profiling and liquid biopsy into standard care, liquid biopsy in clinical trials, and the future of ADC diagnostics, including AI applications. The summit aims to build a precision medicine pathway for Australian patients.
Why it matters for Translyx
This summit highlights the growing focus on precision medicine and AI in oncology within Australia, directly aligning with Translyx's precision medicine pipeline and the application of digital pathology AI in cancer diagnostics.
Up next
More from the feed
45 storiesCancer specialists warn of five-week delays for results due to overwhelmed pathology labs.
Regulating AI Like a Doctor: FDA Floats Competency-Based Path for Generative AI-Enabled Devices
Advancing sepsis care through collaboration and innovation
Leica Biosystems brings Tempus pathology products to Aperio AI Store, accelerating AI-powered capabilities for oncology research
Sepsis & AMR Detection: Rapid Molecular Diagnostics
AI-assisted pathology tool tackles cancer coding
AI-assisted pathology tool tackles cancer coding
Mayo Clinic Laboratories Invests in Pathology Asia Holdings and LifeStrands Genomics to Advance Diagnostics and Precision Medicine
Mayo Clinic Laboratories Invests in Pathology Asia Holdings and LifeStrands Genomics to Advance Diagnostics and Precision Medicine
Mayo Clinic Laboratories Invests in Pathology Asia Holdings and LifeStrands Genomics to Advance Diagnostics and Precision Medicine
Mayo Clinic Laboratories invests in Pathology Asia Holdings and LifeStrands Genomics to advance diagnostics and precision medicine
Mayo Clinic Laboratories Invests in Pathology Asia Holdings and LifeStrands Genomics to Advance Diagnostics and Precision Medicine
Mayo Clinic Laboratories Invests in Pathology Asia Holdings and LifeStrands Genomics to Advance Diagnostics and Precision Medicine
Biomarkers, CDx & Precision Medicine US
AI in Pathology Market Set for Strong Growth Through 2034 as Digital Diagnostics, Automation and Precision Medicine Unlock New Opportunities
New Australia-first test offers advanced monitoring for thyroid cancer patients
MGI launches VisiOmics in Europe and unveils AI-enabled pathology portfolio at ECP 2026
Australian Clinical Labs (ASX:ACL) FY26 Results Highlight Efficiency Gains and Pathology Growth Initiatives
ADLM Calls for CLIA Updates to Address AI in Laboratory Medicine
ADLM calls for CLIA updates to help ensure safe and reliable use of AI in laboratory medicine
ADLM calls for CLIA updates to help ensure safe and reliable use of AI in laboratory medicine
MGI Tech Launches VisiOmics in Europe and Unveils AI-Enabled Pathology Portfolio at ECP 2026
MGI Tech Launches VisiOmics in Europe and Unveils AI-Enabled Pathology Portfolio at ECP 2026
A new era of digital haematology to speed up critical medical diagnoses.
A new era of digital haematology to speed up critical medical diagnoses.
Generative AI Is Coming to Medical Devices. FDA Is Already Thinking About What Comes Next.
Beyond the Algorithm: What Does It Take to Make AI Work in Everyday Pathology?
AI Spatial Analysis Predicts Pancreatic Cancer Recurrence, Mayo Clinic Study
AI-Enabled Spatial Analysis Could Help To Predict Pancreatic Cancer Recurrence Risk
AI trained to 'think' like human pathologists may be better at spotting cancer
New Australia-first test offers advanced monitoring for thyroid cancer patients.
FDA GenAI Medical Device Regulation: What Healthcare Security and Compliance Teams Must Do Now
FDA Seeks Feedback on Potential Regulation of GenAI Medical Devices
Diagnostics target exceeded as waitlists fall 21 per cent
Diagnostics target exceeded as waitlists fall 21 per cent
Global Governments Intensify AI in Medicine Regulation
Global Governments Intensify AI in Medicine Regulation - KuCoin
New blueprint for regulation of artificial intelligence (AI) in healthcare published
AI medical tools used in “potentially life threatening” scenarios need tighter checks, says head of UK government review
AI medical tools used in “potentially life threatening” scenarios need tighter checks, says head of UK government review | The BMJ
Optiscan Imaging (ASX:OIL) Passes 80-Case Milestone in ACL Digital Pathology Study
Aiforia Names 2026 AI Navigator Award Winners at ECP
Optiscan Imaging (ASX:OIL) Passes 80-Case Milestone in ACL Digital Pathology Study
Co:Lab 2026 — New Zealand's pathology lab sector forum to convene in Wellington
Artera receives FDA clearance for ArteraAI Breast, expanding its AI platform
News summaries are AI-assisted and source-linked. They are provided for market awareness and do not represent medical, regulatory, or investment advice. Always verify details with the original source.
Upcoming events in diagnostics & pathology
Conferences, forums, and summits across New Zealand, Australia, and globally that shape the diagnostics, digital pathology, and clinical-AI landscape Translyx works in.
Event listings are for awareness only and do not imply Translyx attendance, sponsorship, or affiliation. Confirm dates and details with each organiser.
Bring your innovation to New Zealand and Oceania.
If you are a diagnostic, pathology, or clinical-AI innovator looking to reach the New Zealand and Oceania market, talk to Translyx about partnership and adoption pathways.